Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03726151 · ClinicalTrials.gov registry record · NA
Comparative Effectiveness of System Interventions to Increase HPV Vaccine Receipt in FQHCs
A NA study, sponsored by University of California, Los Angeles.
- Completed
- Registry status
- NA
- Development phase
- 17,000
- Enrollment target
NCT03726151: Completed NA study, sponsored by University of California, Los Angeles.
NCT03726151 is a NA study that has completed, run by University of California, Los Angeles. The registered enrollment target is 17,000 participants, above the 1,403-participant average among 58,714 other NA trials with a reported enrollment target (1112% higher). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT03726151, a NA study, has completed, sponsored by University of California, Los Angeles.
- COMPLETED
- Registry status
- NA
- Development phase
- 17,000 participants
- Enrollment target
Study Summary
UCLA and Northeast Valley Health Center (NEVHC), a large, multi-site Federally Qualified Health Center (FQHC), are partnering to address underutilization of the prophylactic HPV vaccine among underserved, ethnic minority adolescents receiving care through FQHCs. We will use a cluster randomized 2x2 stepped-wedge factorial study design, implemented in seven NEVHC clinics, to compare the effectiveness of parent reminders (mailed and text), multi-component clinic system strategies, a combined intervention (parent reminders + clinic system strategies) and usual care on HPV vaccine series completion among NEVHC adolescent patients. FQHCs provide essential health care to underserved groups and have the infrastructure to sustain effective strategies to improve preventive care delivery. Therefore, study findings will be invaluable for informing future efforts to improve HPV vaccination at the population-level.
Primary Outcome
We will assess completion of the HPV vaccine series based on the number and the timing of the HPV vaccine doses received according to data in NEVHC's electronic health record system. We will determine completion status based on guidelines from the CDC Advisory Committee on Immunization Practices. For adolescents who initiated the HPV vaccine series before the age of 15, completion will be defined as receiving 2 doses of the HPV vaccine a minimum of 5 months apart. For adolescents who initiated t
Interventions
- BEHAVIORAL Parent Reminders
- BEHAVIORAL Multicomponent clinic-system strategies
- BEHAVIORAL Combined Condition
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 17,000 participants |
| Start Date | 2018-05-01 |
| Est. Completion | 2024-05-31 |
| Phase | NA |
What the finished NCT03726151 record still lists
NCT03726151 is an interventional study that assigns participants to a tested intervention. Its 17,000 participants enrollment target places it among the larger protocols in the corpus, above the 1,403-participant average among 58,714 other NA trials with a reported enrollment target (1112% higher).
The record links to 0 conditions, and to 3 interventions - of which Parent Reminders is the first listed.
NCT03726151 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT03726151 about?
NCT03726151 is a clinical study titled "Comparative Effectiveness of System Interventions to Increase HPV Vaccine Receipt in FQHCs". UCLA and Northeast Valley Health Center (NEVHC), a large, multi-site Federally Qualified Health Center (FQHC), are partnering to address underutilization of the prophylactic HPV vaccine among underserved, ethnic minority adolescents receiving care through FQHCs. We will use a cluster randomized 2x2 ...
What is the current status of trial NCT03726151?
This trial is currently completed. It is a NA study. The enrollment target is 17,000 participants. The study started on 2018-05-01. Estimated completion is 2024-05-31.
What interventions are being tested in trial NCT03726151?
The interventions under investigation include: Parent Reminders (BEHAVIORAL), Multicomponent clinic-system strategies (BEHAVIORAL), Combined Condition (BEHAVIORAL).
Who is sponsoring clinical trial NCT03726151?
This trial is sponsored by University of California, Los Angeles, which has 897 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT03726151's enrollment target sits among peer trials
17,000 11th of 2000 higher than 1,989 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT06479447 · 17,000 participants · NA
Patient Outcome Reporting for Timely Assessments of Life With Post-Traumatic Stress Disorder
- NCT06948838 · 16,895 participants · NA
Improving Hypertension Control in Safety-Net Settings: The Boston Hypertension Equity Alliance in Treatment
- NCT06245187 · 17,198 participants
Get With the Guidelines Atrial Fibrillation Registry
- NCT06951867 · 16,640 participants
Tezspire Cardiac Events PASS
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI